These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10100303)

  • 1. Liposomes with incorporated MHC class II/peptide complexes as antigen presenting vesicles for specific T cell activation.
    van Rensen AJ; Wauben MH; Grosfeld-Stulemeyer MC; van Eden W; Crommelin DJ
    Pharm Res; 1999 Feb; 16(2):198-204. PubMed ID: 10100303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes.
    van Rensen AJ; Taams LS; Grosfeld-Stulemeyer MC; van Eden W; Crommelin DJ; Wauben MH
    Pharm Res; 2000 Jun; 17(6):720-6. PubMed ID: 10955847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.
    Walden P; Nagy ZA; Klein J
    J Mol Cell Immunol; 1986; 2(4):191-7. PubMed ID: 2978228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes.
    Tran CN; Davis MJ; Tesmer LA; Endres JL; Motyl CD; Smuda C; Somers EC; Chung KC; Urquhart AG; Lundy SK; Kovats S; Fox DA
    Arthritis Rheum; 2007 May; 56(5):1497-506. PubMed ID: 17469112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
    Zhou G; Ding ZC; Fu J; Levitsky HI
    J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells.
    Arnold PY; Mannie MD
    Eur J Immunol; 1999 Apr; 29(4):1363-73. PubMed ID: 10229104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
    Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
    Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response.
    Mallet-Designe VI; Stratmann T; Homann D; Carbone F; Oldstone MB; Teyton L
    J Immunol; 2003 Jan; 170(1):123-31. PubMed ID: 12496391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells.
    Watschinger B; Gallon L; Carpenter CB; Sayegh MH
    Transplantation; 1994 Feb; 57(4):572-6. PubMed ID: 8116044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of regulatory T-lymphocyte responses by liposomes carrying major histocompatibility complex molecules and foreign antigen.
    Walden P; Nagy ZA; Klein J
    Nature; 1985 May 23-29; 315(6017):327-9. PubMed ID: 3873617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.
    McConnell HM; Wada HG; Arimilli S; Fok KS; Nag B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2750-4. PubMed ID: 7708718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-presenting hybridoma cells expressing MHC antigens of the LEW rat.
    Matsuda C; Yokota A; Izumi T; Shinohara N
    J Immunol Methods; 2001 May; 251(1-2):93-100. PubMed ID: 11292485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide specificity of thymic selection of CD4+CD25+ T cells.
    Pacholczyk R; Kraj P; Ignatowicz L
    J Immunol; 2002 Jan; 168(2):613-20. PubMed ID: 11777953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.
    Afridi S; Hoessli DC; Hameed MW
    Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens.
    Rott O; Tontsch U; Fleischer B
    J Immunol; 1993 Jan; 150(1):87-95. PubMed ID: 7678036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-coupled antigens are internalized by antigen-presenting cells via pinocytosis and cross-presented to CD8 T cells.
    Tanaka Y; Taneichi M; Kasai M; Kakiuchi T; Uchida T
    PLoS One; 2010 Dec; 5(12):e15225. PubMed ID: 21179411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.